Navigation Links
Sanford-Burnham and Daiichi Sankyo form alliance to study novel drug targets
Date:5/21/2014

Orlando, Fla., U.S., and Tokyo, Japan(May 21, 2014) Sanford-Burnham Medical Research Institute (Sanford-Burnham) and Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) today announced they have entered into a three-year comprehensive alliance to develop first-in-class therapeutics for the treatment of cardiovascular-metabolic diseases. The collaboration is built on an open-innovation model to bridge the gap between target discovery and pre-clinical drug development.

This collaboration focuses on identifying, validating, and screening novel drug targets, and studying new mechanisms of disease. The Sanford-Burnham team will identify and validate targets in collaboration with Cardiovascular-Metabolics Research Laboratories at Daiichi Sankyo. After the validation of the targets, collaboration teams will conduct drug screening to identify compounds that modulate the targets using facilities at both sites.

"The partnership will focus on the broad area of cardiovascular-metabolic diseases, which is a primary research area for Sanford-Burnham as well as a critical unmet medical need worldwide," said Dwight Towler, M.D., Ph.D., professor and director of the Cardiovascular Pathobiology Program at Sanford-Burnham. "Strategic partnerships such as this one serve as a key component of our Institute's 10-year vision to translate basic research discoveries into innovative therapies more quickly. Today's announcement represents another milestone for Sanford-Burnham as we connect our expertise in both basic research and drug discovery technology with pharmaceutical partners to implement this patient-oriented initiative."

"This is a unique and innovative early-stage drug discovery collaboration," said Dr. Masahiko Ohtsuki, Corporate Officer and Global Head of Research, Daiichi Sankyo. "The cardiovascular-metabolic area is a key priority for Daiichi Sankyo and we have found a strong, strategic partner in Sanford-Burnham. I am excited about this collaboration and look forward to seeing results of this partnership."


'/>"/>
Contact: Patrick Bartosch
pbartosch@sanfordburnham.org
407-745-2097
Sanford-Burnham Medical Research Institute
Source:Eurekalert  

Related biology news :

1. Sanford-Burnham presents cancer research at AACR
2. Sanford-Burnham receives US Air Force grant to perform next-generation toxicity screens
3. Sanford-Burnham Medical Research Institute and Mayo Clinic extend collaborative agreement
4. Sanford-Burnham and 60° Pharmaceuticals to pursue promising target for the treatment of dengue fever
5. Sanford-Burnham and Intrexon Corporation establish collaboration to accelerate stem cell research
6. NIH New Innovator Award helps Sanford-Burnham scientist pursue high-risk, high-reward project
7. Californias stem cell agency boosts heart disease research at Sanford-Burnham
8. International patient alliance to fund Spanish Friedreichs ataxia gene-therapy project
9. EcoHealth Alliance and Bat Conservation International forge partnership to work on global bat conservation and public health issues
10. Official opening of wildlife health genetic and forensic laboratory between EcoHealth Alliance and Sabah Wildlife Department
11. The China National Genebank accelerates growth by a strategic alliance with BioStorage Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sanford-Burnham and Daiichi Sankyo form alliance to study novel drug targets
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft ... 8.8% over the next decade to reach approximately $14.21 billion by ... and forecasts for all the given segments on global as well ...
(Date:3/22/2017)... 2017 Vigilant Solutions , a vehicle ... agencies, announced today the appointment of retired FBI special ... safety business development. Mr. Sheridan brings more ... a focus on the aviation transportation sector, to his ... Mr. Sheridan served as the Aviation Liaison Agent Coordinator ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial ... ...
Breaking Biology News(10 mins):
(Date:4/24/2017)... , ... April 24, 2017 , ... ... thermal denaturation in a cellular milieu; however, the broad application of this cellular ... simple platforms with sensitive quantitative readouts. Cell-based thermal stabilization assays are valuable methods ...
(Date:4/21/2017)... Storrs, Conn. (PRWEB) , ... April 21, 2017 ... ... Innovations (CI) and Webster Bank, today announced first round funding to three startups ... to provide early-stage financial support to new business startups affiliated with UConn. , ...
(Date:4/21/2017)... ... 21, 2017 , ... Frederick Innovative Technology Center, Inc. (FITCI), ... businesses, recently earned a $77,518 grant from the Rural Maryland Council (RMC) to ... is Frederick’s first incubator. A non-profit corporation, FITCI is a public-private partnership of ...
(Date:4/20/2017)... BARBARA, CALIFORNIA (PRWEB) , ... April 20, 2017 , ... ... optimization firm for the life sciences and healthcare industries, is pleased to announce ... the new established USDM subsidiary “USDM Europe GmbH” based in Germany. , Braemer ...
Breaking Biology Technology: